Premier News

Medical and Regulatory Affairs

Chief Medical Officer Discussing Early Regulatory Engagement at OCT Southern California

DURHAM, N.C., November 2, 2018 — Premier Research’s Chief Medical Officer will discuss bridging the regulatory engagement gap from pre-clinical to first patient in at Outsourcing in Clinical Trials New England, November 6, in Boston. Dr. Colin Hayward will address strategic and practical considerations for engaging with regulatory bodies on the opening day of the annual...

Rare Disease and Pediatrics Expert to Address WODC Europe November 7

DURHAM, N.C., October 30, 2018 — Angi Robinson, Executive Director for Rare Disease and Pediatrics at Premier Research, will discuss clinical development strategies for genetic rare disease research November 7 at the World Orphan Drug Congress in Barcelona. Ms. Robinson’s presentation, starting at 2:20 p.m., will examine management of confirmatory testing and specialty labs, the...

Premier Research Asia-Pacific Expansion Helps Biotech Advance Life-Changing Therapies

DURHAM, N.C., September 27, 2018 — Premier Research, a leading provider of clinical development and consulting services to biotech and specialty pharma companies, has again expanded its presence in the Asia-Pacific region to include South Korea, Singapore, and Taiwan. The moves increase activities in Australia and New Zealand, where Premier has been conducting clinical trials...

Medical and Regulatory Affairs

Evaluating Europe’s New Device Rules: Join Us in La Jolla September 26

DURHAM, N.C., September 20, 2018 — Implementation of Europe’s new medical device regulations in 2017 started a transition that gives device companies up to five years to fully comply with strict new quality standards. But exactly what is changing, and why? And how will the new MDR and IVDR rules affect the players in this...

Premier Research Names Karen M. Brown VP of Marketing

DURHAM, N.C., September 19, 2018 — Premier Research, a leading provider of clinical development services to biotech and specialty pharma companies, has named Karen M. Brown Vice President of Marketing. She is responsible for developing strategic marketing plans to the company’s commercial objectives, brand, and position in the life sciences industry. Ms. Brown has spent...

Data Management & Biostatistics

Discover the Vital Intersection Where Data Ops Meets Quality Assurance at SCDM

Join us at SCDM 2018 for a session chaired by Sara Doolittle, Associate Director of Data Operations While quality assurance and data operations are generally considered separate entities in clinical drug research, in theory and in practice they are intertwined at multiple levels involving numerous stakeholders. Sara Doolittle, Premier Research’s Associate Director of Data Operations,...